Skip to main content Skip to section navigation Skip to footer
Maravai LifeSciences
  • Contact
  • About
    • About Maravai
    • Leadership
    • Board of Directors
    • Innovation
    • Supply Chain
    • Operations
    • Our People
  • Brands
    • Our Brands
    • TriLink BioTechnologies
    • Cygnus Technologies
    • Glen Research
    • Alphazyme
  • Impact
    • Our Impact
    • Maravai Foundation
  • Insights
    • Our Insights
    • Latest news
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • SEC Filings
    • Sustainability
    • Governance
  • Careers
    • Be a #MiracleMaker
    • Current Openings
    • Benefits and Growth
    • Culture and People

Press releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
    • R&D Day 2023
  • Company Info
    • Company Profile
    • Leadership
    • Annual Reports & Proxy
    • Contacts
    • FAQ
    • Analyst Coverage
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Sustainability
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Whistleblower Policy
  • News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
  • R&D Day 2023
Aug 4, 2022 4:51 PM EDT

Maravai Lifesciences Reports Second Quarter 2022 Financial Results

Jul 19, 2022 8:00 AM EDT

Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 4, 2022

Jul 6, 2022 4:05 PM EDT

TriLink BioTechnologies, part of Maravai LifeSciences, Expands R&D Leadership Team

Jun 27, 2022 8:00 AM EDT

Maravai LifeSciences Strengthens Executive Leadership Team to Support Long-Term Growth

May 24, 2022 8:00 AM EDT

TriLink BioTechnologies, Part of Maravai LifeSciences, Announces Cooperative Agreement With Department of Defense

May 11, 2022 4:05 PM EDT

Maravai LifeSciences Announces May and June 2022 Investor Conference Schedule

May 5, 2022 4:05 PM EDT

Maravai LifeSciences Reports First Quarter 2022 Financial Results

Apr 21, 2022 5:01 PM EDT

Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 5, 2022

Mar 9, 2022 4:30 PM EST

Maravai LifeSciences Announces March 2022 Investor Conference Schedule

Feb 23, 2022 4:05 PM EST

Maravai LifeSciences Reports Fourth Quarter and Full Year 2021 Financial Results and Updates 2022 Financial Guidance

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
Maravai LifeSciences and its brands are the proven catalysts for helping deliver novel vaccines, therapeutics and diagnostics with biotech, biopharma and life sciences companies across the globe.

Extraordinary science.
Everyday miracles.

  • About
    • Leadership
    • Board of Directors
    • Innovation
    • Supply chain
    • Operations
    • Diversity, equity, and inclusion
  • Brands
    • TriLink BioTechnologies
    • Cygnus Technologies
    • Glen Research
    • Alphazyme
  • Helpful links
    • Investors
    • Insights
    • Be a #MiracleMaker
    • Current openings

Connect with us

  • LinkedIn
  • Terms
  • Privacy notice
  • Site map
© 2025 Maravai LifeSciences. All rights reserved